Wells Fargo Maintains Overweight on MannKind, Lowers Price Target to $13

Benzinga Newsdesk www.benzinga.com Negative 88.4%

Neg 88.4% Neu 0% Pos 0%

Wells Fargo analyst Benjamin Burnett maintains MannKind (NASDAQ:MNKD) with a Overweight and lowers the price target from $14 to $13.